Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases

Ann Rheum Dis. 2023 Jun;82(6):883-885. doi: 10.1136/ard-2022-223464. Epub 2023 Jan 31.
No abstract available

Keywords: Autoimmune Diseases; Covid-19; Tumor Necrosis Factor Inhibitors; Vaccination.

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Antibodies, Viral
  • Humans
  • Immunization*
  • Seroconversion
  • Vaccination*

Substances

  • Antibodies, Viral